Background: In US men, prostate cancer is the most common noncutaneous cancer and the
second leading cause of cancer death. Screening for prostate cancer is controversial …

Purpose: The epidemiology and treatment of prostate cancer have changed dramatically in
the prostate specific antigen era. A large disease registry facilitates the longitudinal …

Background We sought to identify determinants of health-related quality of life after primary
treatment of prostate cancer and to measure the effects of such determinants on satisfaction …

Background We evaluated symptoms and self-assessments of quality of life in men with
localized prostate cancer who participated in a randomized comparison between radical …

Background: Men treated for clinically localized prostate cancer with either radical
prostatectomy or external beam radiotherapy usually survive many years with the side …

Purpose: Prior studies of postoperative outcomes following radical prostatectomy have been
limited by selection bias and short-term followup. In this study we assessed temporal …

Background: Radical prostatectomy and external beam radiotherapy are the two major
therapeutic options for treating clinically localized prostate cancer. Because survival is often …

BACKGROUND The psychological difficulties facing men with prostate cancer are
acknowledged widely, yet identifying men who may benefit from mental health treatment has …

BACKGROUND. The primary treatments for clinically localized prostate cancer confer
equivalent cancer control for most patients but disparate side effects. In the current study, the …

Purpose Although it is the most powerful predictor of early prostate cancer treatment-related
complications and quality-of-life (QOL) outcomes, most studies do not stratify results by …